0000899243-23-005471.txt : 20230217
0000899243-23-005471.hdr.sgml : 20230217
20230217162347
ACCESSION NUMBER: 0000899243-23-005471
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DANSEY ROGER D
CENTRAL INDEX KEY: 0001741836
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 23642944
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-15
0
0001060736
Seagen Inc.
SGEN
0001741836
DANSEY ROGER D
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
President, R&D & CMO
Common Stock
2023-02-15
4
M
0
10000
72.64
A
106853
D
Common Stock
2023-02-15
4
S
0
200
138.62
D
106653
D
Common Stock
2023-02-15
4
S
0
7185
140.55
D
99468
D
Common Stock
2023-02-15
4
S
0
2615
141.04
D
96853
D
Non-Qualified Stock Option (Right to Buy)
72.64
2023-02-15
4
M
0
10000
0.00
D
2029-08-30
Common Stock
10000
38083
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Reflects sales of common stock executed in multiple transactions at prices ranging from $139.87 to $140.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $140.88 to $141.45. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Options vested at a rate of 25% on 8/30/2020. The remainder shall vest monthly until all the options are vested on 8/30/2023.
By: /s/ Jennifer Prosba For: Roger D. Dansey
2023-02-17